Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis.
about
Atherosclerosis and infection: is the jury still not in?Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritisAngiotensin II induced inflammation in the kidney and in the heart of double transgenic ratsLack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteriesNewly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodiesNew perspectives of infections in cardiovascular diseaseProductive and Penicillin-Stressed Chlamydia pecorum Infection Induces Nuclear Factor Kappa B Activation and Interleukin-6 Secretion In Vitro.An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.Hydrodynamic regulation of monocyte inflammatory response to an intracellular pathogen.Atherosclerosis, inflammation, and infection.Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.Interactions of Chlamydia pneumoniae with human endothelial cells.The association of infection and coronary artery disease: an update.The treatment of traumatic brain injury with velcade.Assessment of subclinical atherosclerosis and cardiovascular risk.Helicobacter pylori infection and eye diseases: a systematic review.Coagulation and thrombosis in cardiovascular disease: plausible contributions of infectious agents.Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infectionThioredoxin-1 attenuates early graft loss after intraportal islet transplantation in mice.The Differential Effect of Toxoplasma Gondii Infection on the Stability of BCL2-Family Members Involves Multiple Activities.Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?Antibiotic trials for coronary heart disease.Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection.Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.Chlamydophila pneumoniae infection in patients undergoing carotid artery stent.Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae.Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical optionsIncreased infiltration of Chlamydophila pneumoniae in the vessel wall of human veins after perfusion.The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cellsChlamydia pneumoniae GroEL1 protein is cell surface associated and required for infection of HEp-2 cellsChlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice.Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia.Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.Burden of infection and fat mass in healthy middle-aged men.
P2860
Q22241306-1B9F1952-54C1-4DC7-A55B-F22BF9020F72Q24791856-AF868C02-137D-4A60-8B9E-BAB3DE8DC1DDQ24792825-D095FA25-36B5-40FD-BE3E-B2A35AB7D64FQ24800784-258C727F-C5B9-4D79-A6B2-324CE0C298DFQ24802081-1607F0E8-8B29-4F52-BA6D-A5C8F62F61F2Q30821899-DC28E74E-1737-4D39-A413-BFB97C47B8B6Q33587960-E0F94972-39E8-428A-B76E-37BB88BBD09BQ33658962-3E674D64-1F4D-4E95-91CB-46ABF636FFBEQ33763278-D7F52104-B59A-45B8-BF7C-3B6EAD85DAE0Q33797689-A27F0399-5D2E-40CA-98E4-2B27F03830DFQ33843534-1E81CDA8-3B10-42E2-AC6C-58B5FB1EA555Q33935003-632223AA-59E4-4363-AD01-1459E72B0D5DQ33935050-F30B5284-5ED8-4162-BB6E-887A75906B76Q34075142-4989E00F-7496-47FB-8175-F5E845B291D2Q34254813-61FF434A-7FBA-4D93-859B-878A6360D0DAQ34397021-F4780C34-1352-48B3-A1AC-8B4107AF46FAQ34454857-0114436A-E997-4D97-9EC9-5E2DDDB9B43CQ34557671-6D515D52-F160-4B0E-9F44-E18E630BE498Q34581245-AEC64844-D621-4C64-AE42-CF2B5E854479Q34946641-AADF833E-2E56-48B5-A7A9-CCC27BF3F7C9Q35029111-FBD88CE4-AF32-4175-8A7C-65393FE1F951Q35535328-B0B70799-D127-482F-8E01-BDA013D8914AQ35583908-A7BFDCA2-0ADF-40D1-9B65-5B86E94ADCFEQ35701591-CF4FF52A-4F6D-40DC-B6AF-EF35940B9F70Q35733945-BA422C7F-9731-4A1A-9D25-3317CD8299D8Q35758705-4A6128FC-6CD5-4C25-ABDB-78639B78C13EQ36165742-7A7FBE20-9A7C-47A1-BEB8-892152EDD49EQ36673413-DE777ED9-C4A6-4A08-9A9A-198A8560118FQ37775097-F3B6D212-D99E-42C2-B7CD-90321AAEBE5DQ37846181-13C438AC-171F-4A55-BCD3-ECED52F715C0Q37851529-5CC45CC3-0148-4B1C-902A-52939B9D3789Q37855802-B8A4D295-94AB-4E83-B0D7-8B08042A598FQ37856198-33ED5A6E-1417-4117-9E59-9FB379BA0DE5Q37857441-38274A44-D9F9-476C-A696-7A81AD675204Q37857559-D6D8D04F-16DA-425A-9BB7-D68B8D1DEC32Q37857945-AA2870F3-6A07-44CA-B308-BFC160955DC2Q37858665-7BE49DB0-8C0D-4C82-8E99-284086FA2D85Q37860365-9365E0A2-2DFC-456B-AC1B-97F83CC45FDFQ37860435-C9B0F001-D95B-439C-84CA-071197F402A9Q37860560-F036570E-083C-4D8D-8A85-DE28BB0BC321
P2860
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@en
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@nl
type
label
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@en
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@nl
prefLabel
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@en
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@nl
P2093
P1433
P1476
Chlamydia pneumoniae infection ...... accelerated arteriosclerosis.
@en
P2093
P304
P356
10.1161/01.CIR.100.13.1369
P407
P50
P577
1999-09-01T00:00:00Z